Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice
Authors
Keywords
-
Journal
JOURNAL OF MEDICAL VIROLOGY
Volume 90, Issue 9, Pages 1431-1437
Publisher
Wiley
Online
2018-05-02
DOI
10.1002/jmv.25212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiviral therapies on the horizon for influenza
- (2016) Lieve Naesens et al. CURRENT OPINION IN PHARMACOLOGY
- Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease
- (2015) Agnieszka Rynda-Apple et al. INFECTION AND IMMUNITY
- Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
- (2015) Joanna Dobson et al. LANCET
- Bispecific antibody generated with sortase and click chemistry has broad antiinfluenza virus activity
- (2014) Koen Wagner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
- (2014) Stella G Muthuri et al. Lancet Respiratory Medicine
- Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections
- (2013) H. E. Ghoneim et al. JOURNAL OF IMMUNOLOGY
- Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire
- (2013) Mark J. Kwakkenbos et al. METHODS
- Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods
- (2012) Ha T Nguyen et al. ANTIVIRAL THERAPY
- Effectiveness of Seasonal Influenza Vaccines in the United States During a Season With Circulation of All Three Vaccine Strains
- (2012) J. J. Treanor et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
- (2012) Mark L. Metersky et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Corticosteroid Treatment in Critically Ill Patients with Pandemic Influenza A/H1N1 2009 Infection
- (2011) Sung-Han Kim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Development and evaluation of a four-tube real time multiplex PCR assay covering fourteen respiratory viruses, and comparison to its corresponding single target counterparts
- (2011) Rogier R. Jansen et al. JOURNAL OF CLINICAL VIROLOGY
- Antivirals and resistance: influenza virus
- (2011) Michael G Ison Current Opinion in Virology
- Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection
- (2010) I. Martin-Loeches et al. INTENSIVE CARE MEDICINE
- Postinfluenza Bacterial Pneumonia: Host Defenses Gone Awry
- (2010) Megan N. Ballinger et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Influenza Virus Infection Decreases Tracheal Mucociliary Velocity and Clearance ofStreptococcus pneumoniae
- (2009) Lynnelle A. Pittet et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming
- (2009) Mark J Kwakkenbos et al. NATURE MEDICINE
- Improving therapeutic strategies for secondary bacterial pneumonia following influenza
- (2008) Jonathan A McCullers et al. Future Microbiology
- Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection
- (2008) Arnaud Didierlaurent et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection
- (2008) Keer Sun et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now